BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11549250)

  • 1. Syndecan-4 as antithrombin receptor of human neutrophils.
    Kaneider NC; Egger P; Dunzendorfer S; Wiedermann CJ
    Biochem Biophys Res Commun; 2001 Sep; 287(1):42-6. PubMed ID: 11549250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Syndecan-4 mediates antithrombin-induced chemotaxis of human peripheral blood lymphocytes and monocytes.
    Kaneider NC; Reinisch CM; Dunzendorfer S; Römisch J; Wiedermann CJ
    J Cell Sci; 2002 Jan; 115(Pt 1):227-36. PubMed ID: 11801740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Syndecan-4-dependent migration of human eosinophils.
    Feistritzer C; Kaneider NC; Sturn DH; Wiedermann CJ
    Clin Exp Allergy; 2004 May; 34(5):696-703. PubMed ID: 15144459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparan sulfate proteoglycans are involved in opiate receptor-mediated cell migration.
    Kaneider NC; Dunzendorfer S; Wiedermann CJ
    Biochemistry; 2004 Jan; 43(1):237-44. PubMed ID: 14705951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Syndecan-4-dependent signaling in the inhibition of endotoxin-induced endothelial adherence of neutrophils by antithrombin.
    Kaneider NC; Förster E; Mosheimer B; Sturn DH; Wiedermann CJ
    Thromb Haemost; 2003 Dec; 90(6):1150-7. PubMed ID: 14652650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-surface heparan sulfate proteoglycan-mediated regulation of human neutrophil migration by the serpin antithrombin III.
    Dunzendorfer S; Kaneider N; Rabensteiner A; Meierhofer C; Reinisch C; Römisch J; Wiedermann CJ
    Blood; 2001 Feb; 97(4):1079-85. PubMed ID: 11159540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukocyte motility in response to neuropeptides is heparan sulfate proteoglycan dependent.
    Kaneider NC; Egger P; Djanani AM; Wiedermann CJ
    Peptides; 2003 May; 24(5):695-700. PubMed ID: 12895655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Syndecan-1 is involved in osteoprotegerin-induced chemotaxis in human peripheral blood monocytes.
    Mosheimer BA; Kaneider NC; Feistritzer C; Djanani AM; Sturn DH; Patsch JR; Wiedermann CJ
    J Clin Endocrinol Metab; 2005 May; 90(5):2964-71. PubMed ID: 15728209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Syndecan-4 is a signaling molecule for stromal cell-derived factor-1 (SDF-1)/ CXCL12.
    Charnaux N; Brule S; Hamon M; Chaigneau T; Saffar L; Prost C; Lievre N; Gattegno L
    FEBS J; 2005 Apr; 272(8):1937-51. PubMed ID: 15819887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Syndecan-4 in the cellular invasion of Orientia tsutsugamushi.
    Kim HR; Choi MS; Kim IS
    Microb Pathog; 2004 Apr; 36(4):219-25. PubMed ID: 15001228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparan sulfate proteoglycans are increased during skeletal muscle regeneration: requirement of syndecan-3 for successful fiber formation.
    Casar JC; Cabello-Verrugio C; Olguin H; Aldunate R; Inestrosa NC; Brandan E
    J Cell Sci; 2004 Jan; 117(Pt 1):73-84. PubMed ID: 14627628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of a CXCL8 binding site on endothelial syndecan-3 in rheumatoid synovium.
    Patterson AM; Gardner L; Shaw J; David G; Loreau E; Aguilar L; Ashton BA; Middleton J
    Arthritis Rheum; 2005 Aug; 52(8):2331-42. PubMed ID: 16052590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of human neutrophil chemotaxis toward interleukin 8 with six clinical antithrombin concentrates in vitro.
    Kaneider NC; Rabensteiner A; Reinisch CM; Dunzendorfer S; Wiedermann CJ
    Intensive Care Med; 2002 Oct; 28(10):1447-52. PubMed ID: 12373470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and function of syndecan-4 in human platelets.
    Kaneider NC; Feistritzer C; Gritti D; Mosheimer BA; Ricevuti G; Patsch JR; Wiedermann CJ
    Thromb Haemost; 2005 Jun; 93(6):1120-7. PubMed ID: 15968398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PR-39 coordinates changes in vascular smooth muscle cell adhesive strength and locomotion by modulating cell surface heparan sulfate-matrix interactions.
    Chon JH; Houston MM; Xu C; Chaikof EL
    J Cell Physiol; 2001 Nov; 189(2):133-43. PubMed ID: 11598898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synectin, syndecan-4 cytoplasmic domain binding PDZ protein, inhibits cell migration.
    Gao Y; Li M; Chen W; Simons M
    J Cell Physiol; 2000 Sep; 184(3):373-9. PubMed ID: 10911369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localisation of specific heparan sulfate proteoglycans during the proliferative phase of brain development.
    Ford-Perriss M; Turner K; Guimond S; Apedaile A; Haubeck HD; Turnbull J; Murphy M
    Dev Dyn; 2003 Jun; 227(2):170-84. PubMed ID: 12761845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Focal adhesion kinase regulates syndecan-2-mediated tumorigenic activity of HT1080 fibrosarcoma cells.
    Park H; Han I; Kwon HJ; Oh ES
    Cancer Res; 2005 Nov; 65(21):9899-905. PubMed ID: 16267014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Src tyrosine kinase-dependent migratory effects of antithrombin in leukocytes.
    Feistritzer C; Mosheimer BA; Tancevski I; Kaneider NC; Sturn DH; Patsch JR; Wiedermann CJ
    Exp Cell Res; 2005 Apr; 305(1):214-20. PubMed ID: 15777801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Syndecan-4 clustering induces cell migration in a PDZ-dependent manner.
    Tkachenko E; Elfenbein A; Tirziu D; Simons M
    Circ Res; 2006 Jun; 98(11):1398-404. PubMed ID: 16675718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.